Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,040 | 753 | 1,747 | 3,381 | 6,540 |
| Cost of Goods | 574 | 334 | 1,452 | 2,845 | 5,639 |
| Gross Profit | 466 | 419 | 295 | 536 | 901 |
| Operating Expenses | 25,854 | 21,919 | 20,736 | 23,328 | 22,629 |
| Operating Income | -24,814 | -21,166 | -19,989 | -21,947 | -21,089 |
| Interest Expense | 2,951 | 555 | 2,206 | 1,005 | 891 |
| Other Income | 1,591 | 2,630 | 1,413 | 2,125 | 2,424 |
| Pre-tax Income | -26,174 | -19,091 | -20,782 | -20,827 | -19,556 |
| Income Tax | 32 | 24 | 30 | 11 | 36 |
| Net Income Continuous | -26,206 | -19,115 | -20,812 | -20,838 | -19,592 |
| Minority Interests | -2,832 | -1,003 | -54 | N/A | N/A |
| Net Income | $-23,374 | $-18,112 | $-20,758 | $-20,838 | $-19,592 |
| EPS Basic Total Ops | -8.30 | -7.00 | -8.10 | -8.10 | -7.70 |
| EPS Basic Continuous Ops | -9.31 | -7.42 | -8.08 | -8.12 | -7.70 |
| EPS Diluted Total Ops | -8.30 | -7.00 | -8.10 | -8.10 | -7.70 |
| EPS Diluted Continuous Ops | -9.31 | -7.42 | -8.08 | -8.12 | -7.70 |
| EPS Diluted Before Non-Recurring Items | -8.30 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-22,087 | $-18,397 | $-17,969 | $-19,802 | $-18,810 |